Skip to main content
. 2022 Apr 18;22(7):1737–1753. doi: 10.1111/ajt.17017

TABLE 1.

Characteristics of included studies

Study Outcome Sample size Data source and study design Demographics Socioeconomic status
Mean age Female sex (%) Race and ethnicity (%) Insurance (%) Education (%)
2010, Friedman Perioperative complications 6320 Cross‐sectional analysis using discharge data (1995–2005) from the HCUP‐NIS, ICD‐9 diagnostic, and procedure codes (1999–2005) from cases of patients undergoing LKD. Mean LOS: 3.3 days 40 59

n = 4329

Hispanic: 11

Black: 12

Other▪: 6

White: 68

n = 6210 Private: 44

Self‐Pay: 13

Medicare: 13 Medicaid 2

No charge 1

Other: 26

NR
2010, Lentine ◊ CKD, CVD, DM, HTN 4650

Linkage of OPTN data (1987–2007) with administrative billing claims from a private health insurer (2000–2007)

CKD outcome evaluated among coding subgroup of 2307 LKDs. Median follow‐up: 7.7 yrs

37 55

Hispanic: 8.2

Non‐Hispanic Black: 13.1

Non‐Hispanic White: 76.3

Other▪: 2.4

Private: 100

n = 3385

  • College graduate

  • Hispanic: 23

  • Black: 21

  • White: 28

<12th grade

  • Hispanic 27

  • Black 23

  • White: 16

2010, Segev Mortality 80 347 Linkage of OPTN LKD data (1994–2009) and SSDMF. Median follow‐up: 6.3 yrs 18–39: 49 40–49: 30 50–59: 17 ≥60: 4 59

n = 80 286

Hispanic: 12.3

Black: 13.1

Other□: 1.6

White: 73.1

NR

n = 41 146

GS: 2

HS: 36

Some college: 28

College graduate: 24

Post‐college: 10

2011, Lentine DM, HTN (accounted for relatedness to recipient) 4650 Linkage of OPTN data (1987–2007) with administrative billing claims from a private health insurer (2000–2007) See Lentine 2010
2014, Lentine Am J Nephrol HTN 4650 Linkage of OPTN data (1987–2007) with administrative billing claims from a private health insurer (2000–2007), specifically using pharmacy fills See Lentine 2010
2014, Lentine Transp. CKD, DM, HTN 4007 Linkage of OPTN data (1987–2008) with Medicare‐insured living donors. Median follow‐up: 6 yrs 55 60

Hispanic: 5.7

Non‐Hispanic Black: 8.1

Non‐Hispanic White: 83.4

Other▪: 2.8

Medicare: 100 NR
2014, Muzaale ESKD 96 217 Linkage of OPTN LKD data (1994–2011) and national kidney replacement treatment records. Healthy controls from NHANES III (screened for health exclusions to donation, matched by demographic and clinical factors) LKD. Median follow‐up: 7.6 yrs 40 59

Hispanic: 12.5

Black: 12.9

White/other □: 74.6

NR

HS or less: 36

Some college: 28

College graduate: 25

Post college: 10

2014, Schold Rehospitalization 4524 Retrospective cohort using State Inpatient Databases compiled by AHRQ. Data from North Carolina, New York, Florida, California. Follow‐up: 731 days 41 n = 386160

n = 3395

Hispanic: 21

Black: 10

White: 63

NR NR
2015, Lam Gout 4650 Linkage of OPTN data (1987–2007) with administrative billing claims from a private health insurer (2000–2007) See Lentine 2010
2015, Lentine

Proteinuria

Nephrotic syndrome

Nephritis/nephropathy

Renal failure,

any kidney diagnosis,

CKD

(accounting for relatedness)

4650 Linkage of OPTN data (1987–2007) with administrative billing claims from a private health insurer (2000–2007) See Lentine 2010
2016, Anjum

ESKD, early (0–9 yrs), and late (10–25 yrs) post‐donation by subtype:

  • DM‐related

  • HTN‐related

  • GN‐related

125 427 Linkage of OPTN data (1987–2014) and national kidney replacement treatment records. Median follow‐up: 11 yrs 40 59

Hispanic: 12

Black: 13

White or other▪: 75

NR

HS or less: 35

Attended college: 28

Graduate or more: 37

2016, Lentine Perioperative complications 14 964 Linkage of OPTN data (2008–2012) with UHC database, an alliance of 107 academic medical centers and 234 of affiliated hospitals. Follow‐up: perioperative period 42 62

Hispanic: 11

Black: 12

Other: 5

White: 72

Insured: 73

Uninsured: 12

Missing: 15

NR
2017, Massie ESKD 133 824 Linkage of OPTN data (1987–2015) and national kidney replacement treatment records, SSDMF. Median follow‐up: NR 40* ESKD: 39 No ESKD: 59

Hispanic: % NR ESKD, Black: 34

No ESKD, Black: 13

NR NR
2018, Wainright ESKD 123 526 Linkage of OPTN LKD data (1994–2016) and national kidney replacement treatment records, SSDMF. Median follow‐up: 10.3 ESKD: 38 No ESKD: 41 ESKD: 42 No ESKD: 60

ESKD

  • Hispanic: 11.0

  • Black: 32.1

  • Other□: 5.1

  • White: 51.8

No ESKD

  • Hispanic: 12.9
  • Black: 12.3
  • Other□: 4.8
  • White: 70.1
NR NR
2019, Holscher

Early (within first 2 yrs post‐donation)

  • DM

  • HTN

41 260 Linkage of OPTN data (2008–2014) with OPTN living donor follow‐up form data. Max follow‐up: 2 yrs 42* 62

Hispanic ethnicity, reported separately from race: 14 Race:

  • White: 84

  • Asian: 4

  • Black: 12

  • Other▪: 1

Insured 73

Uninsured: 13

Unknown: 14

Some college or higher

  • Yes: 64

  • No: 27

  • Unknown: 9

2019, Lentine

DM

  • Primary: anti‐diabetic medications use

  • Non‐insulin anti‐diabetic med use

  • Insulin use

28 515 Retrospective cohort study using a large US pharmaceutical claims data warehouse‐ comprises National Council for Prescription Drug Program 5.1‐format prescription claims aggregated from multiple sources including data clearinghouses, retail pharmacies, and prescription benefit managers (2007 to 2016). Mean follow‐up: 3.8 yrs 43 67

Hispanic: 12

White: 74

Black: 11

Other▪: 4

Insured: 79

Uninsured: 10

Unknown: 11

College or higher: 67

GS/HS: 25

Unknown: 8

2020, Muzaale ESKD, stratified by biological relatedness 143 750 Linkage of OPTN LKD data (1987–2017) and national kidney replacement treatment records. Median follow‐up: 12 yrs 40 59

Hispanic: 13

Asian: 3

Black: 12

White: 72

NR

College graduate: 26

Post‐graduate education: 11

2021, Augustine Change in eGFR, proteinuria 34 504 LKD data (2008–2014) from the SRTR registry. Max follow‐up: 2 yrs 42 63

Hispanic: 13.7

Black: 11.0

Other▪: 4.8

White: 70.5

Insured: 85

HS or less: 29

Some college or higher: 71

▪ other, not explicitly defined; ◊ same cohort (original study: Lentine et al., 2010); *median; median time follow‐up from donation to the end of observed insurance benefits; □ other, defined as American Indian, Native Hawaiian, Alaskan Native, Pacific Islander, and multiracial.

Abbreviations: AHRQ, Agency for Healthcare Research and Quality; Am J Nephrol, American Journal of Nephrology; CKD, chronic kidney disease; CVD, cardiovascular disease; DM, diabetes mellitus; ESKD, end‐stage kidney disease; GN, glomerulonephritis, eGFR, estimated glomerular filtration rate; GS, grade school; HCUP‐NIS, Healthcare Cost and Utilization Project‐National (Nationwide) Inpatient Sample; HS, high school; HTN, hypertension; LKD, living kidney donor; LOS, length of stay; NHANES, National Health and Nutrition Examination Survey; NR, not reported; OPTN, Organ Procurement and Transplantation Network; SRTR, Scientific Registry of Transplant Recipients; SSDMF, Social Security Death Master File; Transp, Transplantation; yrs, years.